PHVS

31.4300.73%
BA

Berndt Axel Edvard Modig

Co-Founder, CEO & Executive Director

Mr. Berndt Axel Edvard Modig, MBA, CPA, serves as Chief Executive Officer of Pharvaris B.V. since 2015 and serves as its Executive Director since September 30, 2015. Mr. Modig served as a Member of the Supervisory Board at Centogene N.V. since April 2018 until August 15, 2023. He is a co-Founder of Pharvaris B.V. Mr. Modig has been a Member of Supervisory Board at Centogene GmbH (formerly known as Centogene AG) since May 2018. Mr. Modig served as the Chief Financial Officer of Prosensa Holding N.V., a pharmaceutical company, from March 2010 until its acquisition by BioMarin Pharmaceutical Inc. in January 2015 and served as Principal Accounting Officer and Member of Management Board. Mr. Modig served as Chief Financial Officer and Member of the Management Board of Shire Orphan Therapies GmbH (also known as Jerini AG) from October 2003 to November 2008. He was a Partner in the Brussels-based private equity firm Agra Industria from 1994 to 1999. Mr. Modig served as Chief Financial Officer of Surplex AG from 2001 to 2003. From 1999 to 2001, he served as European Finance Director of US-based Hayward Industrial Products Inc., Hayward Manager in the Financial Services Industry Group of Price Waterhouse LLP in New York, where he began his career as an Accountant in Audit and Assurance Services. He served as Senior Manager in the Financial Services Industry Group of Price Waterhouse LLP in New York from 1991 to 1994. He serves as a Vice Chairman of Supervisory Board since 2016. He served as Investment Manager at IMM GmbH. He has extensive international experience in finance and operations, private equity and mergers and acquisitions. He had been an Independent Director of Sio Gene Therapies, Inc. (formerly known as Axovant Gene Therapies Ltd.). (formerly known as Axovant Sciences Ltd.) since March 2015 until 2023. He served as Director of Auris Medical Holding AG from April 2014 to March 12, 2018. He had been a Director at Affimed N.V. since September 2014 until August 2020. He served as Vice Chairman of Supervisory Board at Kiadis Pharma N.V. since June 2016 until April 2021 and served as its Member of Supervisory Board since July 04, 2016. He served as a Director of Mobile Loyalty Holding AB from May 31, 2012 to May 31, 2013. He served as a Director of Genovis AB. He is a Certified Public Accountant (inactive) and has an MBA from INSEAD in Fontainebleau, France. He holds BS in International Economics from Lund University. Mr. Modig has a bachelor’s degree in business administration in economics and German from the University of Lund, Sweden.

Positions